# LEVETIRACETAM

NDC: 36000-265
Generic name: levetiracetam
Labeler / Manufacturer: Baxter Healthcare Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20260806

FDA application: ANDA208458

## Active ingredients

- LEVETIRACETAM: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"36000-265"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=36000-265
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e381590-1147-46f3-9cbd-dc9716013444